Table 2. Clinical characteristics of case-patients with Guillain-Barré syndrome (N = 50) in the Salvador metropolitan area—Brazil, 2015.
| N (%) or median [IQR] | |
|---|---|
| Time between onset of previous illness and onset of neurological symptoms, d | 8 [5–15] |
| Time from onset of symptoms until nadir, days | 6 [4–9] |
| Symptoms at onset | |
| Lower extremity weakness | 20 (40) |
| Upper extremity weakness | 3 (6) |
| Facial weakness | 4 (8) |
| Lower extremity paresthesias | 29 (58) |
| Upper extremity paresthesias | 17 (34) |
| Facial paresthesias | 1 (2) |
| Dysphagia | 1 (2) |
| Diplopia/ophthalmoplegia | 0 (0) |
| Gait disturbance | 5 (10) |
| Symptoms at any time | |
| Lower extremity weakness | 35 (70) |
| Upper extremity weakness | 35 (70) |
| Facial weakness | 25 (50) |
| Lower extremity paresthesias | 20 (40) |
| Upper extremity paresthesias | 22 (44) |
| Facial paresthesias | 9 (18) |
| Dysphagia | 25 (50) |
| Diplopia/ophthalmoplegia | 3 (6) |
| Gait disturbance | 4 (8) |
| Cytoalbuminologic dissociation | 44 (88) |
| Level of care | |
| Hospitalized | 50 (100) |
| Intensive care | 17 (34) |
| Mechanical ventilation | 11 (22) |
| Intravenous immune globulin | 46 (92) |